45 related articles for article (PubMed ID: 7911838)
1. Impaired insulin clearance in essential hypertension.
Swislocki AL
J Hum Hypertens; 1994 Mar; 8(3):185-90. PubMed ID: 7911838
[TBL] [Abstract][Full Text] [Related]
2. Insulin increases forearm vascular resistance in obese, insulin-resistant hypertensives.
Gudbjörnsdottir S; Elam M; Sellgren J; Anderson EA
J Hypertens; 1996 Jan; 14(1):91-7. PubMed ID: 12013500
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance in patients with essential hypertension can occur in the absence of microalbuminuria.
Yip JW; Jones C; Facchini F; Chen I; Reaven GM
Am J Hypertens; 1996 Oct; 9(10 Pt 1):959-63. PubMed ID: 8896647
[TBL] [Abstract][Full Text] [Related]
4. Insulin resistance and hypertension in postmenopausal women.
Feldstein CA; Akopian M; Renauld A; Olivieri AO; Cauterucci S; Garrido D
J Hum Hypertens; 2002 Mar; 16 Suppl 1():S145-50. PubMed ID: 11986914
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of insulin resistance in essential hypertension.
Lind L; Berne C; Lithell H
J Hypertens; 1995 Dec; 13(12 Pt 1):1457-62. PubMed ID: 8866908
[TBL] [Abstract][Full Text] [Related]
6. [The effect of insulin in primary hyperaldosteronism].
Sindelka G; Widimský J; Prázný M; Hilgertová J; Skrha J
Cas Lek Cesk; 1998 May; 137(11):338-40. PubMed ID: 9727207
[TBL] [Abstract][Full Text] [Related]
7. Decreased insulin clearance as a feature of essential hypertension.
Salvatore T; Cozzolino D; Giunta R; Giugliano D; Torella R; D'Onofrio F
J Clin Endocrinol Metab; 1992 Jan; 74(1):144-9. PubMed ID: 1727814
[TBL] [Abstract][Full Text] [Related]
8. Effect of weight loss on blood pressure and insulin resistance in normotensive and hypertensive obese individuals.
Su HY; Sheu WH; Chin HM; Jeng CY; Chen YD; Reaven GM
Am J Hypertens; 1995 Nov; 8(11):1067-71. PubMed ID: 8554729
[TBL] [Abstract][Full Text] [Related]
9. [Effect of insulin in hypertension with high and low levels of renin].
Sindelka G; Widimský J; Prázný M; Kasalová Z; Skrha J
Cas Lek Cesk; 2001 Apr; 140(7):205-8. PubMed ID: 11374224
[TBL] [Abstract][Full Text] [Related]
10. Blood pressure and serum potassium levels in hypertensive patients receiving or not receiving antihypertensive treatment.
Pikilidou MI; Lasaridis AN; Sarafidis PA; Tziolas IM; Zebekakis PE; Dombros NV; Giannoulis E
Clin Exp Hypertens; 2007 Nov; 29(8):563-73. PubMed ID: 18058481
[TBL] [Abstract][Full Text] [Related]
11. Relationship between hyperinsulinemia and ambulatory blood pressure monitoring of lean and overweight male hypertensives.
Feldstein CA; Renauld A; Akopian M; Olivieri AO; Garrido D
J Cardiovasc Risk; 1998 Feb; 5(1):25-30. PubMed ID: 9816552
[TBL] [Abstract][Full Text] [Related]
12. Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients.
Colussi G; Catena C; Lapenna R; Nadalini E; Chiuch A; Sechi LA
Diabetes Care; 2007 Sep; 30(9):2349-54. PubMed ID: 17575088
[TBL] [Abstract][Full Text] [Related]
13. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate.
Al-Waili N
Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866
[TBL] [Abstract][Full Text] [Related]
14. [Assessment of selected markers of inflammation in patients with clinical symptoms of insulin resistance and normal renal function].
Bogdański P; Pupek-Musialik D; Luczak M; Szulińska M
Pol Merkur Lekarski; 2006 Aug; 21(122):165-8; discussion 169. PubMed ID: 17144103
[TBL] [Abstract][Full Text] [Related]
15. Urinary and plasma endothelin 1 in essential hypertension and in hypertension secondary to renoparenchymal disease.
Zoccali C; Leonardis D; Parlongo S; Mallamaci F; Postorino M
Nephrol Dial Transplant; 1995; 10(8):1320-3. PubMed ID: 8538921
[TBL] [Abstract][Full Text] [Related]
16. Impaired basal glucose effectiveness but unaltered fasting glucose release and gluconeogenesis during short-term hypercortisolemia in healthy subjects.
Nielsen MF; Caumo A; Chandramouli V; Schumann WC; Cobelli C; Landau BR; Vilstrup H; Rizza RA; Schmitz O
Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E102-10. PubMed ID: 12965873
[TBL] [Abstract][Full Text] [Related]
17. Reduction in resting metabolic rate and ratio of plasma leptin to urinary nitric oxide: influence on obesity-related hypertension.
Golan E; Tal B; Dror Y; Korzets Z; Vered Y; Weiss E; Bernheim J
Isr Med Assoc J; 2002 Jun; 4(6):426-30. PubMed ID: 12073415
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor alpha -238 and -308 polymorphisms do not associate with insulin resistance in hypertensive subjects.
Sheu WH; Lee WJ; Lin LY; Chang RL; Chen YT
Metabolism; 2001 Dec; 50(12):1447-51. PubMed ID: 11735091
[TBL] [Abstract][Full Text] [Related]
19. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.
Kotronen A; Juurinen L; Tiikkainen M; Vehkavaara S; Yki-Järvinen H
Gastroenterology; 2008 Jul; 135(1):122-30. PubMed ID: 18474251
[TBL] [Abstract][Full Text] [Related]
20. Metabolic risk factors in white coat hypertensives.
Marchesi E; Perani G; Falaschi F; Negro C; Catalano O; Ravetta V; Finardi G
J Hum Hypertens; 1994 Jul; 8(7):475-9. PubMed ID: 7932508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
